Wing-Wai Wong Selected Research

RNA (Ribonucleic Acid)

1/2019	Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption.
1/2017	Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings.
1/2016	Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wing-Wai Wong Research Topics

Disease

5	Infections 01/2019 - 03/2002
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 03/2002
4	HIV Infections (HIV Infection) 01/2017 - 09/2002
2	Tuberculosis (Tuberculoses) 01/2019 - 01/2013
2	Bacteremia 12/2004 - 06/2002
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Dizziness (Lightheadedness) 01/2019
1	Viremia 01/2019
1	Exanthema (Rash) 01/2019
1	Sleep Wake Disorders 01/2019
1	Malaria 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Anemia 01/2017
1	Obesity 01/2017
1	Hepatitis B 01/2016
1	Coinfection 01/2016
1	Hepatitis C 01/2016
1	Latent Tuberculosis 01/2013
1	Hyperlipidemias (Hyperlipidemia) 08/2011
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 11/2010
1	Uveitis 03/2007
1	Heart Failure 06/2005
1	Fever (Fevers) 06/2005
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2005
1	Neoplasms (Cancer) 12/2004
1	Shock 12/2004
1	Thrombocytopenia (Thrombopenia) 12/2004
1	Diarrhea 03/2004
1	Escherichia coli Infections 09/2003
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2003
1	secondary Syphilis 09/2002
1	Retinitis 03/2002
1	Cytomegalovirus Infections (Inclusion Disease) 03/2002

Drug/Important Bio-Agent (IBA)

3	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2007 - 09/2003
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2007 - 06/2005
1	UB-421IBA 01/2019
1	RacivirIBA 01/2019
1	efavirenz (Sustiva)FDA Link 01/2019
1	Emtricitabine (Emtriva)FDA Link 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	Lamivudine (Epivir)FDA Link 01/2019
1	doravirineIBA 01/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Tuberculin (PPD)IBA 01/2013
1	InterferonsIBA 01/2013
1	Atazanavir Sulfate (Reyataz)FDA Link 08/2011
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 11/2010
1	Cefixime (Suprax)FDA Link 11/2010
1	DNA (Deoxyribonucleic Acid)IBA 02/2008
1	Clarithromycin (Biaxin)FDA LinkGeneric 03/2007
1	Mydriatics (Cycloplegics)IBA 03/2007
1	Rifabutin (Ansamycin)FDA Link 03/2007
1	Serum AlbuminIBA 12/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2004
1	Interleukin-8 (Interleukin 8)IBA 03/2004
1	InterleukinsIBA 03/2004
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2003
1	beta-Lactamases (beta-Lactamase)IBA 09/2003
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 09/2003
1	Cephalosporins (Cephalosporin Antibiotics)IBA 09/2003
1	Ceftazidime (Fortum)FDA LinkGeneric 09/2003
1	EnzymesIBA 09/2002
1	ImmunosorbentsIBA 09/2002
1	Anti-Infective Agents (Microbicides)IBA 06/2002
1	deoxyuridine triphosphateIBA 03/2002
1	Retinaldehyde (Retinal)IBA 03/2002
1	Caspase 3 (Caspase-3)IBA 03/2002
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2002
1	Retinal Pigments (Pigments, Visual)IBA 03/2002
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2002

Therapy/Procedure

6	Therapeutics 01/2019 - 12/2003
2	Highly Active Antiretroviral Therapy (HAART) 08/2011 - 12/2003
1	Intravenous Infusions 01/2019
1	Art Therapy 01/2016
1	Steam Bath (Sauna) 12/2011
1	Respiratory Therapy (Therapy, Respiratory) 06/2005
1	Central Venous Catheters 12/2004
1	Length of Stay 06/2003